STOCK TITAN
  1. Home
  2. Sec-filings
  3. LIVN
  4. [SCHEDULE 13G/A] LivaNova PLC SEC Filing

[SCHEDULE 13G/A] LivaNova PLC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock LIVN logo
Livanova Plc

NASDAQ:LIVN

LIVN Rankings

#2718 Ranked by Market Cap
N/A Ranked by Dividends

LIVN Latest News

Jul 9, 2025
LivaNova to Announce Second-Quarter 2025 Results
Jun 5, 2025
CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
Jun 5, 2025
LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy
Jun 4, 2025
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
May 15, 2025
LivaNova to Present at the Jefferies Global Healthcare Conference

LIVN Stock Data

2.54B
54.31M
0.33%
104.41%
2.91%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United Kingdom
LONDON